Filing Details

Accession Number:
0000899243-23-003059
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-31 17:24:21
Reporting Period:
2023-01-27
Accepted Time:
2023-01-31 17:24:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1788028 Jasper Therapeutics Inc. JSPR () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
933790 Tc Group, Llc C/O The Carlyle Group
1001 Pennsylvania Ave. Nw, Suite 220S
Washington DC 20004-2505
No No Yes No
1354120 Carlyle Investment Management Llc C/O The Carlyle Group
1001 Pennsylvania Ave. Nw, Suite 220S
Washington DC 20004-2505
No No Yes No
1397144 Llp Abingworth 38 Jermyn Street,
London, England X0 SW1Y 6DN
No No Yes No
1527166 Carlyle Group Inc. C/O The Carlyle Group
1001 Pennsylvania Ave. Nw, Suite 220S
Washington DC 20004-2505
No No Yes No
1548626 Carlyle Holdings I Gp Inc. C/O The Carlyle Group
1001 Pennsylvania Ave. Nw, Suite 220S
Washington DC 20004-2505
No No Yes No
1548627 L.l.c. Sub Gp I Holdings Carlyle C/O The Carlyle Group
1001 Pennsylvania Ave. Nw, Suite 220S
Washington DC 20004-2505
No No Yes No
1548628 L.p. I Holdings Carlyle C/O The Carlyle Group
1001 Pennsylvania Ave. Nw, Suite 220S
Washington DC 20004-2505
No No Yes No
1790577 L.l.c. Holdings Subsidiary Cg C/O The Carlyle Group
1001 Pennsylvania Ave. Nw, Suite 220S
Washington DC 20004-2505
No No Yes No
1941860 Carlyle Genesis Uk Llc C/O The Carlyle Group
1001 Pennsylvania Ave. Nw, Suite 220S
Washington DC 20004-2505
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Voting Common Stock Acquisiton 2023-01-27 3,133,333 $1.50 8,761,891 No 4 P Indirect See footnotes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnotes
Footnotes
  1. Reflects securities held of record by Abingworth Bioventures VII LP ("ABV VII"). ABV VII has delegated to Abingworth LLP all investment and dispositive power over the securities held of record by ABV VII.
  2. The Carlyle Group Inc., which is a publicly traded entity listed on Nasdaq, is the sole shareholder of Carlyle Holdings I GP Inc., which is the sole member of Carlyle Holdings I GP Sub L.L.C., which is the general partner of Carlyle Holdings I L.P., which, with respect to the securities reported herein, is the managing member of CG Subsidiary Holdings L.L.C., which is the managing member of TC Group, L.L.C., which is the managing member of Carlyle Investment Management, L.L.C., which is the sole member of Carlyle Genesis UK LLC, which is the principal member of Abingworth LLP. Accordingly, each of the foregoing entities may be deemed to share beneficial ownership of the securities held of record by ABV VII, but each disclaims beneficial ownership of such securities except to the extent of their pecuniary interest therein, if any.